VRTX
Vertex Pharmaceuticals Inc
Price:  
462.11 
USD
Volume:  
1,377,922.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Vertex Relative Valuation

-102.1%
Upside

As of 2025-02-19, the Relative Valuation of Vertex Pharmaceuticals Inc (VRTX) is (9.75) USD. This relative valuation is based on P/E multiples. With the latest stock price at 462.11 USD, the upside of Vertex Pharmaceuticals Inc based on Relative Valuation is -102.1%.

The range of the Relative Valuation is (44.87) - 43.58 USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 21.5x - 29.6x 25.6x
Forward P/E multiples 26.6x - 39.5x 30.7x
Fair Price (44.87) - 43.58 (9.75)
Upside -109.7% - -90.6% -102.1%
462.11 USD
Stock Price
(9.75) USD
Fair Price

Vertex Relative Valuation - Historical P/E Data

Date P/E
2025-02-18 -221.65
2025-02-14 -220.16
2025-02-13 -221.88
2025-02-12 -217.38
2025-02-11 -218.35
2025-02-10 -225.42
2025-02-07 -225.11
2025-02-06 -230.79
2025-02-05 -234.28
2025-02-04 -231.33
2025-02-03 -225.61
2025-01-31 -221.44
2025-01-30 -210.28
2025-01-29 -211.77
2025-01-28 -211.37
2025-01-27 -212.91
2025-01-24 -210.86
2025-01-23 -210.92
2025-01-22 -205.29
2025-01-21 -205.24
2025-01-17 -202.41
2025-01-16 -199.99
2025-01-15 -203.50
2025-01-14 -197.45
2025-01-13 -198.27
2025-01-10 -196.45
2025-01-08 -197.67
2025-01-07 -195.85
2025-01-06 -193.05
2025-01-03 -195.27
2025-01-02 -194.62
2024-12-31 -193.15
2024-12-30 -191.55
2024-12-27 -196.06
2024-12-26 -196.97
2024-12-24 -195.78
2024-12-23 -194.39
2024-12-20 -190.55
2024-12-19 -190.25
2024-12-18 -214.64
2024-12-17 -225.07
2024-12-16 -224.52
2024-12-13 -222.43
2024-12-12 -222.61
2024-12-11 -224.61
2024-12-10 -225.06
2024-12-09 -227.34
2024-12-06 -221.65
2024-12-05 -220.60
2024-12-04 -222.55